Intracoronary cardiosphere-derived cells after myocardial infarction: evidence for therapeutic regeneration in the final 1-year results of the CADUCEUS trial.

Submitted by: Erica CurcioGold Contributor

Source: Journal American College of Cardiology
Source URL: http://www.ncbi.nlm.nih.gov/pubmed/24036024

Keywords:

Author(s): K Malliaras, R R. Makkar, R R. Smith, K Cheng, E Wu, R O. Bonow, L Marbán, A Mendizabal, E Cingolani, P V. Johnston, G Gerstenblith, K H. Schuleri, AC. Lardo, E Marbán

This paper describes the 1-year results of the CADUCEUS randomized  trial on the effect of intracoronary delivery of cardiosphere derived cells (CDC) 1.5 to 3 months after  myocardial infarction. Safety endpoints were similar in both groups. Patients treated with CDC had smaller scar size, an increase in viable myocardium and improved regional function of infarcted myocardium than those in the control group. Global ventricular function did not change from baseline to follow up in either group.

Add Comments

ADD TO PLAYLIST

Related Content